Wagner D D, Marder V J
J Cell Biol. 1984 Dec;99(6):2123-30. doi: 10.1083/jcb.99.6.2123.
Biosynthesis of von Willebrand protein by human umbilical vein endothelial cells involved distinct processing steps marked by the presence of several intermediate molecular species. Examination of endoglycosidase H sensitivity of these intracellular intermediates indicated that the processing steps occurred in at least two separate cellular compartments. In the pre-Golgi apparatus (most probably the endoplasmic reticulum), the high mannose carbohydrates were added onto the precursor monomer chains and the 260,000-mol-wt monomers dimerized by interchain disulfide bond formation. The other processing steps have been localized to the Golgi apparatus and later compartments (e.g., Weibel-Palade bodies). High mannose carbohydrate was converted to the complex type, leading to the appearance of a larger precursor subunit of 275,000 mol wt. The 275,000-mol-wt species was not formed if carbohydrate processing was inhibited by the ionophore monensin. From the large pool of dimers of precursor subunits, the high molecular weight multimers were built. These dimer molecules appeared to have free sulfhydryls which might have been involved in the interdimer disulfide bond formation. Simultaneously with multimerization, the precursor subunits were cleaved to the 220,000-mol-wt form. The cleavage of the pro-sequence was not likely to be an absolute requirement for von Willebrand protein multimerization or secretion, as the 275,000-mol-wt precursor subunit was present in secreted high molecular weight multimers of the protein.
人脐静脉内皮细胞合成血管性血友病因子的过程涉及不同的加工步骤,这些步骤以几种中间分子形式的存在为标志。对这些细胞内中间体的内切糖苷酶H敏感性进行检测表明,加工步骤至少发生在两个不同的细胞区室中。在高尔基前体(很可能是内质网)中,高甘露糖碳水化合物被添加到前体单体链上,260,000道尔顿的单体通过链间二硫键形成而二聚化。其他加工步骤定位于高尔基体和后续区室(如魏尔-帕拉德小体)。高甘露糖碳水化合物转变为复合型,导致出现更大的275,000道尔顿前体亚基。如果用离子载体莫能菌素抑制碳水化合物加工,则不会形成275,000道尔顿的分子形式。从前体亚基的大量二聚体库中构建出高分子量多聚体。这些二聚体分子似乎具有游离巯基,可能参与了二聚体间二硫键的形成。在前体亚基多聚化的同时,其被切割成220,000道尔顿的形式。前序列的切割不太可能是血管性血友病因子多聚化或分泌的绝对必要条件,因为在该蛋白分泌的高分子量多聚体中存在275,000道尔顿的前体亚基。